| ADC | antibody-drug conjugate |
| CLL | chronic lymphocytic leukemia |
| CR1 | complement receptor 1, CD35 |
| DARA | daratumumab, specific for CD38 |
| E | erythrocyte |
| EBV | Epstein–Barr virus |
| FcγR | Fcγ receptor |
| HEL | hen egg lysozyme peptide |
| LSEC | liver sinusoidal endothelial cells |
| MM | multiple myeloma |
| OFA | ofatumumab |
| RTX | rituximab |
| TRA | trastuzumab |
| VP | viral particle |